| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.2 | 0.2 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.089 | 0.2 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.23 | 0.2 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.13 | 0.2 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.16 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |